US Stock MarketDetailed Quotes

APGE Apogee Therapeutics

Watchlist
  • 30.370
  • -1.020-3.25%
Close Mar 4 16:00 ET
  • 30.370
  • 0.0000.00%
Post 16:05 ET
1.81BMarket Cap-9.20P/E (TTM)

About Apogee Therapeutics Company

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Company Profile

SymbolAPGE
Company NameApogee Therapeutics
Listing DateJul 14, 2023
Issue Price17.00
Founded2022
CEODr. Michael Henderson, M.D.
MarketNASDAQ
Employees91
Fiscal Year Ends12-31
Address221 Crescent Street,Building 17, Suite 102b
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-650-394-5230
Websitehttp://www.apogeetherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Michael Henderson, M.D.
  • Chief Executive Officer and Director
  • 1.17M
  • Dr. Carl Dambkowski, M.D.
  • Chief Medical Officer
  • 870.83K
  • Jane Pritchett Henderson
  • Chief Financial Officer and Chief Accounting Officer
  • 1.72M
  • Mark C. McKenna
  • Chairman of the Board
  • 972.87K
  • Dr. Lisa L. Bollinger, M.D.
  • Director
  • --
  • William B.J. Jones, Jr
  • Independent Director
  • 411.66K
  • Tomas Kiselak
  • Independent Director
  • 662.82K
  • Peter Harwin
  • Independent Director
  • 668.57K
  • Nimish Shah
  • Independent Director
  • 664.82K
  • Jennifer A. Fox
  • Independent Director
  • 414.57K
  • Dr. Andrew Gottesdiener, M.D.
  • Independent Director
  • 666.57K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LEETRO
430425
+29.97%
Geovis Insighter Technology
920116
+23.98%
Beijing Global Safety Technology
300523
+20.01%
4
Zhejiang JW Precision Machinery
300984
+20.00%
5
Wintao Communications
301139
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
As China's 'two sessions' approach: How will Chinese stocks perform?
🎙️Discussion 1. With China's 'two sessions' approaching, do you focus more on policy dynamics or capital flows? 2. Which industry sectors d Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Earnings Season Underway
Earnings season is here. What to know?